Clinical Trials Recruiting RSS

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Source: Clinical Trials Recruiting Published on 2024-12-16
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
Source: Clinical Trials Recruiting Published on 2024-12-13
The 5-FU Holter Study
Source: Clinical Trials Recruiting Published on 2024-12-09
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Source: Clinical Trials Recruiting Published on 2024-12-06
A Study of BG-C477 in Participants With Advanced Solid Tumors
Source: Clinical Trials Recruiting Published on 2024-12-05
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Source: Clinical Trials Recruiting Published on 2024-12-04
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Source: Clinical Trials Recruiting Published on 2024-12-03
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
Source: Clinical Trials Recruiting Published on 2024-11-28
A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Source: Clinical Trials Recruiting Published on 2024-11-27
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Source: Clinical Trials Recruiting Published on 2024-11-25
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
Source: Clinical Trials Recruiting Published on 2024-10-28
An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.
Source: Clinical Trials Recruiting Published on 2024-10-28
A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
Source: Clinical Trials Recruiting Published on 2024-07-16
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
Source: Clinical Trials Recruiting Published on 2024-07-09
A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
Source: Clinical Trials Recruiting Published on 2024-07-03